Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Trials"
DOI: 10.1177/1740774519836989
Abstract: Symptomatic adverse events are common with cancer therapies, and provide key information about tolerability during development and regulatory review. After a therapy becomes available on the market, information about these adverse events is essential for…
read more here.
Keywords:
information;
symptomatic adverse;
adverse events;
oncology ... See more keywords